Nothing Special   »   [go: up one dir, main page]

Gonder-Frederick et al., 1984 - Google Patents

Patient blood glucose monitoring: Use, accuracy, adherence, and impact

Gonder-Frederick et al., 1984

View PDF
Document ID
62648218472625901
Author
Gonder-Frederick L
Cox D
Pohl S
Carter W
Publication year
Publication venue
Behavioral Medicine Update

External Links

Snippet

Self-measurement of blood glucose (SMBG) is a major tool in contemporary treatment ofType I diabetes. Although 5MBG used in combination with insulin adjustment can, theoretically, normalize metabolism for the diabetic patient, success of the treatment …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/3487—Medical report generation
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/3418—Telemedicine, e.g. remote diagnosis, remote control of instruments or remote monitoring of patient carried devices
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires

Similar Documents

Publication Publication Date Title
Mazze et al. Psychological and social correlates of glycemic control
Glasgow et al. Diabetes-specific social learning variables and self-care behaviors among persons with type II diabetes.
Davis et al. Psychosocial correlates of survival in diabetes
Wysocki et al. Blood glucose monitoring by diabetic adolescents: compliance and metabolic control.
Carney et al. Improving adherence to blood glucose testing in insulin-dependent diabetic children
Kramer et al. Stress and metabolic control in diabetes mellitus: methodological issues and an illustrative analysis
Wysocki Impact of blood glucose monitoring on diabetic control: obstacles and interventions
Wing et al. Frequency and accuracy of self-monitoring of blood glucose in children: relationship to glycemic control
Gowers et al. Family functioning: a correlate of diabetic control?
US20020019707A1 (en) Glucose metering system
Kovacs et al. Intellectual development and academic performance of children with insulin-dependent diabetes mellitus: A longitudinal study.
US20030125609A1 (en) Method for reliable measurement in medical care and patient self monitoring
Niemcryk et al. Psychosocial correlates of hemoglobin A1c in young adults with type I diabetes
Cox et al. Intensive versus standard blood glucose awareness training (BGAT) with insulin-dependent diabetes: mechanisms and ancillary effects.
Du Pasquier-Fediaevsky et al. Discordance between physician and adolescent assessments of adherence to treatment: influence of HbA1c level. The PEDIAB Collaborative Group.
Gonder-Frederick et al. Blood glucose symptom beliefs of diabetic patients: Accuracy and implications.
Cox et al. Blood glucose discrimination training in insulin-dependent diabetes mellitus (IDDM) patients
Delamater et al. Physiologic responses to acute psychological stress in adolescents with type 1 diabetes mellitus
Delamater et al. Self-monitoring of blood glucose by adolescents with diabetes: technical skills and utilization of data
Carney et al. The effects of blood glucose testing versus urine sugar testing on the metabolic control of insulin-dependent diabetic children
Northam et al. Neuropsychological functioning in adolescents with diabetes
Joubert et al. Indication, organization, practical implementation and interpretation guidelines for retrospective CGM recording: A French position statement
Gonder-Frederick et al. Patient blood glucose monitoring: Use, accuracy, adherence, and impact
Tozzo et al. Estimating Glycemia From HbA1c and CGM: Analysis of Accuracy and Sources of Discrepancy
Gill et al. Random blood glucose estimation in type 2 diabetes: does it reflect overall glycaemic control?